Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage
|
|
- Blanche Boyd
- 6 years ago
- Views:
Transcription
1 Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark Jackson, PhD, and Neeraj K. Mediratta, FRCS Departments of Cardiothoracic Surgery and Research and Development, The Cardiothoracic Centre-Liverpool, Liverpool, United Kingdom Background. The left internal mammary artery to the left anterior descending artery is recognized as the gold standard for revascularization. Several studies have shown the benefits of the left internal mammary artery. However, a substantial portion of patients undergoing coronary artery bypass grafting does not receive this conduit. We sought to identify reasons for nonusage of the left internal mammary artery to the left anterior descending artery, while evaluating short- and mediumterm outcomes. Methods. Between April 1997 and September 2001 a total of 4406 consecutive patients underwent coronary artery bypass grafting with revascularization to the left anterior descending artery. All data were collected prospectively except reasons for nonusage of the left internal mammary artery. Logistic regression and Cox proportional hazards analyses were used to adjust in-hospital and medium-term outcomes, respectively. Selection bias was controlled by constructing a propensity score. A case note review was carried out to determine reasons for nonusage. Results. A total of 4047 patients (91.8%) received the left internal mammary artery to the left anterior descending artery leaving 359 patients (8.2%) who did not. We found no difference in hospital mortality or morbidity, however, patients receiving the left internal mammary artery had a survival advantage at 4 years. Reasons for not using the left internal mammary artery were damage to the conduit (n 44), poor flow (n 43), poor lung function (n 45), unstable symptoms (n 24), vascular problems (n 12), and 19 patients with other reasons (previous radiotherapy, chest wall deformity, and obese patients). Case notes had no reason stated for 146 patients and reasons for 26 patients were unobtainable. Conclusions. Left internal mammary artery usage is not associated with any increase in hospital mortality and morbidity, but these patients have better medium-term survival. Injury on harvesting, poor flow, and poor lung function were the most common reasons for not using this conduit. (Ann Thorac Surg 2004;78:142 8) 2004 by The Society of Thoracic Surgeons The left internal mammary artery (LIMA) has been used as a conduit for coronary artery revascularization since 1968 [1]. However, its use has become regular and frequent in the last two decades as its long-term benefits have become apparent [2 4]. Patients who receive LIMA experience better long-term survival, have fewer late myocardial infarctions, and sustain a greater cumulative event-free survival. Several studies have also shown an improved long-term patency. In the past, some doubts have been raised about the in-hospital outcomes and morbidity in patients who received LIMA compared with those who have received vein grafts. However, there have been several reports illustrating that the early outcomes are as good as, if not better, in patients who received LIMA [5 7]. In view of the short- and long-term benefits revealed in various studies [2 7], it would be appropriate to consider Accepted for publication Feb 6, Address reprint requests to Dr Karthik, Yorkshire Heart Centre, Leeds General Infirmary, Great George St, Leeds LS17 8AP, UK; suchkats@yahoo.com. LIMA to be the gold standard conduit of choice for surgical revascularization of the left anterior descending artery (LAD) [8]. Whereas the worldwide trend in the last two decades has been a steady increase in the usage of LIMA, not much is documented about the reasons for not using LIMA. Hence, we have designed a study to look at the experiences at our center with regard to LIMA usage. Although we looked at the patient characteristics and early and midterm outcomes of those having LIMA versus those in whom it was not used, the main focus of this project was to look into the case notes of those patients in whom the LAD was grafted, but LIMA was not used, to determine reasons for nonusage of LIMA. Material and Methods Patient Population and Data A total of 4587 consecutive patients underwent first-time isolated coronary artery bypass graft (CABG) surgery between April 1, 1997 and September 30, 2001 at the Cardiothoracic Centre-Liverpool. One-hundred eighty by The Society of Thoracic Surgeons /04/$30.00 Published by Elsevier Inc doi: /j.athoracsur
2 Ann Thorac Surg KARTHIK ET AL 2004;78:142 8 USE OF THE LIMA TO LAD Abbreviations and Acronyms BMI body mass index CABG coronary artery bypass grafting CCS Canadian Cardiac Society CI confidence intervals COAD chronic obstructive airways disease IABP intra aortic balloon pump ICU intensive care unit LAD left anterior descending artery LIMA left internal mammary artery NSTS National Strategic Tracing Service NYHA New York Heart Association OR odds ratio SWI sternal wound infection one (3.9%) patients did not receive revascularization to the LAD and were excluded from this analysis. This left 4406 patients, who received revascularization to the LAD, as our study group. Data collection methods and definitions have been published previously [9]. Data collected prospectively included variables listed in Table 1 (preoperative) and Table 2 (in-hospital outcomes). A retrospective case note review was carried out to identify reasons for not using LIMA to LAD. In-hospital mortality was defined as death within the same hospital admission regardless of cause. All patients transferred from the base hospital to another hospital were followed up to confirm their status at discharge. Postoperative stroke was defined as a new focal neurologic deficit and/or comatose states occurring postoperatively that persisted for more than 24 hours after its onset. We excluded confused states, transient cerebral events, and intellectual impairment from our study to avoid any subjective bias. Postoperative myocardial infarction was defined as a new Q-wave postoperatively in two or more contiguous leads on an electrocardiogram or notable rise in postoperative creatine-kinase with hemodynamic and echocardiographic signs of myocardial infarction. Postoperative bleeding was defined as bleeding that required surgical reexploration after initial departure from the operating theater. Renal failure was defined as patients with a postoperative creatinine level greater than 200 mol/l or patients requiring dialysis. Criteria for diagnosing superficial and deep sternal wound infections (SWI) were in accordance with the guidelines published by the Centers for Disease Control and Prevention [10]. Patient Follow-Up Patient records were linked to the National Strategic Tracing Service (NSTS), which records all causes of mortality in the United Kingdom to establish current vital statistics (as of July 31, 2002). Patients were matched to the NSTS based on patient name, National Health Service number, date of birth, gender, and postcode. 143 Statistical Analysis Categorical variables are shown as a percentage with 95% confidence intervals (CI). Comparisons were made with 2 tests as appropriate. Standard statistical tests were used to calculate odds ratios (OR) and 95% CI. Parsonnet scores were calculated, modified to a regional standard [9] to assess differences in patient case mix, and are shown as a median with 25th and 75th percentiles. Logistic regression was used to examine the impact of LIMA usage on in-hospital mortality and morbidity, while adjusting for differences in patient characteristics (treatment selection bias) [11]. Deaths occurring as a function of time were described actuarially using the product-limit methodology of Kaplan Meier [12]. To control for treatment selection bias, we used Cox proportional hazards analysis to calculate adjusted relative risk and to risk adjust the Kaplan Meier survival curve [13]. Treatment selection bias was controlled for by constructing a propensity score [14]. The propensity score was the probability that a patient would receive LIMA and was constructed from the variables listed in Table 1 (C statistic 0.75). Once the propensity score is constructed for each patient, there are three ways of using the score for comparisons: matching, stratification, and multivariable adjustment. Because of the small sample size available to us for this study, we have decided to use multivariable adjustment as matching would have reduced the study size even further and stratification can be difficult to interpret. The propensity score is then included along with the comparison variable (LIMA vs no LIMA) in multivariable analyses of outcome producing adjusted OR as shown in Table 2. The propensity score adjusts for the treatment selection bias, which is evident in Table 1, between the two groups [14]. Inall cases a p value less than 0.05 was considered significant. All statistical analysis was performed retrospectively with SAS for Windows Version 8.2 (SAS Institute, Inc., Chicago, IL). Results Left Internal Mammary Artery Use Of the 4406 patients who underwent revascularization of the LAD, 4047 (91.8%) received LIMA. The yearly usage of LIMA has increased from 90.9% in the financial year 1997/1998 to 95.7% in 2000/2001 (p value for trend 0.001). Table 1 lists study characteristics and the rate of LIMA use by patient subgroup. Clinical factors associated with low LIMA use included older age, females, smaller body mass index (BMI), increased severity of angina and dyspnea, poor left ventricular ejection fraction, emergency surgery, on-pump surgery, and patients with comorbid disease (history of diabetes, congestive cardiac failure, respiratory disease, cerebrovascular disease, and renal dysfunction). The median Parsonnet score for the LIMA group was 2.1 (25th and 75th percentiles: ) compared with 4.2 (25th and 75th percentiles: ) in the non-lima group (p 0.001). CARDIOVASCULAR
3 144 KARTHIK ET AL Ann Thorac Surg USE OF THE LIMA TO LAD 2004;78:142 8 Table 1. Patient Characteristics and Rates of LIMA Use % Patients % LIMA Use p Value Age at operation (years) a Gender Male Female Body mass index (kg/m 2 ) a Angina CCS class IV No Yes NYHA class IV No Yes Respiratory disease No Yes Current smoker No Yes Diabetes No Yes Peripheral vascular disease No Yes Cerebrovascular disease No Yes Renal dysfunction No Yes Congestive cardiac failure No Yes Ejection fraction 30% No Yes Three vessel disease No Yes Left main stenosis 50% No Yes Emergency procedure No Yes Off-pump surgery No Yes a 2 test for trend. CCS Canadian Cardiac Society; LIMA left internal mammary artery; NYHA New York Heart Association. Table 2. Crude and Adjusted Odds Ratio for In-Hospital Outcomes (LIMA Versus No LIMA) Crude OR with 95% CI Adjusted a OR with 95% CI Mortality 0.45 ( ) 1.21 ( ) p p Stroke 0.59 ( ) 1.42 ( ) p p Myocardial infarction 0.88 ( ) 1.32 ( ) p p Reop for bleeding 1.54 ( ) 1.79 ( ) p p Renal failure 0.37 ( ) 0.77 ( ) p p Deep SWI 0.59 ( ) 0.77 ( ) p p Superficial SWI 0.52 ( ) 0.56 ( ) p p Inotrope support 0.66 ( ) 1.06 ( ) p p IABP support 0.53 ( ) 1.21 ( ) p p Mechanical ventilation 0.66 ( ) 1.37 ( ) 24 hrs p p ICU stay 3 days 0.61 ( ) 1.12 ( ) p p Postoperative stay ( ) 1.19 ( ) days p p a Adjusted for the propensity score. CI confidence intervals; IABP intraaortic balloon pump; ICU intensive care unit; LIMA left internal mammary artery; OR odds ratio; SWI sternal wound infection. Reasons For Nonusage of LIMA Of the 4406 patients in our study, 5 patients received alternate arterial grafts to the LAD. In all cases, the radial artery was the conduit used. The reasons for not using the LIMA were documented in the patients medical records in 187 cases (52.1%). These included 44 patient cases of damage/injury to LIMA on harvesting, 43 patient cases with poor flow in LIMA, 45 patient cases with poor lung function, 24 patient cases with unstable symptoms, 12 patient cases with vascular complications, and 19 patient cases with other reasons (previous radiotherapy to the chest wall, chest wall deformity, and obese patients with a short sternum). No apparent reason was stated for nonusage of LIMA in 146 patient cases (40.7%), whereas 26 patient case notes were unobtainable (7.2%). In-Hospital Outcomes Crude and adjusted OR for in-hospital outcomes (LIMA vs no LIMA) are shown in Table 2. In-hospital outcomes were adjusted for the propensity score which included emergency surgery, age at operation, off-pump surgery, sex, ejection fraction, cerebrovascular disease, respiratory disease, unstable angina, congestive cardiac failure, and body mass index. Hospital mortality after CABG was 2.0% (95% CI 1.6
4 Ann Thorac Surg KARTHIK ET AL 2004;78:142 8 USE OF THE LIMA TO LAD Table 3. Crude In-Hospital Outcomes Based on LIMA Use LIMA Used (n 4047) LIMA not Used (n 359) p Value 145 CARDIOVASCULAR Mortality 2.0 ( ) 4.5 ( ) Stroke 2.2 ( ) 3.6 ( ) Myocardial infarction 4.2 ( ) 4.7 ( ) Reop for bleeding 2.1 ( ) 1.4 ( ) Renal failure 2.1 ( ) 5.6 ( ) Deep SWI 0.7 ( ) 1.1 ( ) Superficial SWI 2.2 ( ) 4.2 ( ) Inotrope support 31.4 ( ) 40.9 ( ) IABP support 2.3 ( ) 4.2 ( ) Ventilation 24 hrs 5.5 ( ) 8.1 ( ) ICU stay 3 days 8.6 ( ) 13.4 ( ) Postoperative stay 14 days 7.9 ( ) 13.4 ( ) ICU intensive care unit; SWI sternal wound infec- IABP intraaortic balloon pump; LIMA left internal mammary artery; tion. 2.5) in patients receiving LIMA (n 4047) and 4.5% (95% CI ) in patients not receiving LIMA (n 359) (p 0.003; Table 3). After multivariate adjustment was made with the propensity score, patients receiving LIMA compared with patients not receiving LIMA were no longer associated with a lower incidence of in-hospital mortality (Table 4). By univariate analyses there was no demonstrable association between LIMA use and postoperative stroke, myocardial infarction, reexploration for bleeding, and Table 4. In-Hospital Outcomes Based on LIMA Use Adjusted for the Propensity Score LIMA Used (n 4047) LIMA not Used (n 359) p Value Mortality 2.2 ( ) 2.0 ( ) Stroke 2.4 ( ) 1.9 ( ) Myocardial infarction 4.3 ( ) 3.5 ( ) Reop for bleeding 2.2 ( ) 1.3 ( ) Renal failure 2.3 ( ) 2.8 ( ) Deep SWI 0.7 ( ) 0.8 ( ) Superficial SWI 2.3 ( ) 3.6 ( ) Inotrope support 32.2 ( ) 31.4 ( ) IABP support 2.4 ( ) 2.2 ( ) Ventilation 24 hrs 5.8 ( ) 4.8 ( ) ICU stay 3 days 9.1 ( ) 8.4 ( ) Postoperative stay 14 days 8.4 ( ) 7.6 ( ) ICU intensive care unit; SWI sternal wound infec- IABP intraaortic balloon pump; LIMA left internal mammary artery; tion. Fig 1. Observed survival after coronary artery bypass surgery. deep SWI. LIMA patients, however, had lower rates of renal failure, superficial SWI, need for inotrope and intraaortic balloon pump (IABP) support, and a shorter duration of mechanical ventilation, intensive care unit (ICU) length of stay, and total postoperative length of hospital stay (Table 3). After multivariate adjustment with the propensity score, there was no association between LIMA use and postoperative stroke, myocardial infarction, reexploration for bleeding, renal failure, deep and superficial SWI, need for inotrope and IABP support, duration of mechanical ventilation, ICU length of stay and postoperative length of stay (Table 4). Follow-Up Mortality Three-hundred thirty-nine deaths (7.4% [95% CI ]) occurred during the study period, with a mean follow-up of 2.9 years (standard deviation 1.4 years). The crude relative risk of long-term mortality for LIMA patients was 0.47 (p 0.001; Fig 1). Freedom from death in LIMA patients at 30 days, 1 year, 2 years, 3 years, and 4 years was 98.1%, 96.3%, 94.8%, 93.4%, and 92.0%, respectively, compared with 95.2%, 91.1%, 88.9%, 86.9%, and 83.4% for the non-lima patients. After multivariate adjustment for the propensity score, the adjusted relative risk of long-term mortality for LIMA patients was 0.66 (p 0.005). The adjusted Kaplan Meier survival curves are shown in Figure 2. The adjusted freedom from death in the LIMA patients at 30 days, 1 year, 2 years, 3 years, and 4 years was 98.1%, 96.2%, 94.8%, 93.5%, and 92.0%, respectively, compared with 97.1%, 94.3%, 92.3%, 90.3%, and 88.2% for the non-lima patients. Comment Use of LIMA during surgical revascularization can vary between different hospitals and different surgeons. Surgeon specific rates of LIMA use have been shown to be as low as 61% and as high as 97% across the four cardiothoracic centers in the northwest of England (see
5 146 KARTHIK ET AL Ann Thorac Surg USE OF THE LIMA TO LAD 2004;78:142 8 Fig 2. Adjusted survival after coronary artery bypass surgery adjusted for the propensity score. heartaudit.nhs.uk). These variations can be explained partly by variations in case mix and also by differences in surgical practices. This study aimed to quantify reasons for nonusage of LIMA and to examine patient characteristics and outcomes. An analysis of our database revealed several variations in patient characteristics in the LIMA and the non-lima groups. Women were less likely to receive LIMA compared with men. This was illustrated in several previous studies [15 17]. Elderly patients were also less likely to receive LIMA to LAD compared with younger patients. The longer patency of LIMA and its attendant benefits are probably less likely to benefit older patients. Obese patients (BMI 35 kg/m 2 ) were less likely to receive LIMA than nonobese individuals. However, patients with a BMI less than 25 kg/m 2 were also less likely to receive LIMA to the LAD. A previous study has shown a similar relationship with body surface area [16]. Although the reason for this is unclear, a possible reason could be the smaller sizes of LIMA in this subgroup. The rates for LIMA usage were 61.5% in patient cases requiring emergency revascularization compared with 92.5% in the nonemergent group. The case note review revealed this to be a fairly common reason for nonusage of LIMA (0.54% of the total study group). The lower rate of LIMA usage in this group of patients is likely to be due to hemodynamic instability or a greater bleeding risk as these patients are often on antithrombotic and anticoagulant therapy. The perceived prognostic benefits of LIMA may not be as obvious in this group. Upon further analysis of the preoperative variables by multivariate logistic regression, we found elderly patients ( 70years), patients with respiratory diseases, females, diabetics, patients with ejection fraction (EF) less than 30%, and patients undergoing emergency CABG were less likely to receive LIMA to LAD. In the last two decades, LIMA usage has improved worldwide. Several patients, who would have been denied LIMA in the past because of the perceived early risks associated with LIMA usage, are now receiving it more often. There have been several observational studies in the last 10 years demonstrating not only the long-term benefits of LIMA usage, but also illustrating the protective effect of LIMA in the early postoperative period [5, 7]. In our study, there was a considerable difference in the crude mortality rates between the two groups with the patients receiving LIMA doing better. However, after adjusting for propensity score, this favorable effect was no longer evident. This also seems to be the case with the various measures of postoperative morbidity. Although the overall trend is toward a better outcome in the LIMA group, none of the differences were statistically significant after adjusting for the various factors enumerated in Table 1. The reason for this becomes apparent on analyzing the modified Parsonnet scores (0.51 of the calculated Parsonnet score) [9]. Although the median score of the LIMA group was 2.1, that of the non-lima group was 4.2. This indicates that the patients not receiving LIMA were higher risk patients. Hence, on accounting for these differences, there is no marked advantage with regard to in-hospital outcomes. What is quite apparent is that there is certainly no disadvantage in terms of early outcomes in the LIMA group. Several studies have shown some early benefits in patients with LIMA usage; however, no sound mechanism responsible for this advantage has been proposed. Among the reasons advanced for this early benefit are the early higher patency rates of LIMA. This however is debatable. Although Grondin and associates [18] have shown a 1-month occlusion rate of 10.9% for saphenous vein grafts versus 2.6% for IMA grafts, Sethi and associates [19] did not find any difference in the 7 10-day or 1-year patency rates of these two conduits. Dabal and associates [20] have recently shown that LIMA use is associated with better short-term outcomes in all patients including lower mortality rates, lower incidence of ventricular arrhythmias, shorter duration of ventilation and transfusion requirements, and shorter length of stay. They were able to demonstrate these benefits in certain high-risk groups such as women, diabetics, and elderly patients. Another possible reason for the improved operative survival in the LIMA group, especially when the other proximal anastomosis is performed with a side-biting clamp, is the perfusion of this vital territory by LIMA as soon as the cross-clamp is removed [5]. However, this remains speculative and is essentially unproven. Although the early benefits arising out of LIMA usage may be debatable, there have been several studies in the literature showing the long-term survival benefits of LIMA [3, 4]. In our study, we have been able to show a definite survival advantage for patients in whom LIMA was used and this advantage seems to be increasing with the passage of time. At 4 years, the adjusted freedom from death for the LIMA patients was 92%, whereas for patients without LIMA usage it was 88.2%. This is in accordance with most of the studies published. To identify practices with regard to LIMA usage, we carried out a case note review of the patients who did not
6 Ann Thorac Surg KARTHIK ET AL 2004;78:142 8 USE OF THE LIMA TO LAD have LIMA used. In 1% of the study population, the cause was injury to LIMA while harvesting. In another 1%, the LIMA was discarded after harvesting as it was deemed to have poor flow. In another 1% of the patient cases, LIMA was not harvested either because of poor lung function, chronic obstructive airways disease (COAD), or emphysematous lungs. Patients who were too unstable before surgery and those who needed inotropic agents/iabp on induction of anesthesia or had cardiac arrest before sternotomy were the other major group of patients not receiving LIMA (0.54%). Arteriopaths and patients with extensive peripheral vascular diseases and arch vessel diseases were another subset of patients who did not receive LIMA to LAD. Among the other reasons for not using the LIMA were previous radiotherapy to the chest wall, chest wall deformity, and obese patients with a short sternum. We acknowledge that often reasons mentioned in patient case notes represent the judgment of an individual surgeon to a given clinical situation. This study has definitely made us aware of a variety of reasons that may prevent LIMA usage in specific cases. One of the positive outcomes of this study has been a change in our data collection so that we can now collect reasons for not using the LIMA in individual cases. We anticipate that this will provide us with valuable information in the future which might help in regulating our practice further. A recent study of the Society of Thoracic Surgeons database reveals a LIMA usage of 81% across all coronary revascularization procedures in the United States [21]. We believe that a better awareness of reasons for nonusage of LIMA will probably lead to a gradual increase in this figure. We accept that LIMA usage will never be 100%; our aim during CABG should be to reach as close to that figure as possible with valid reasons for not using it in selected cases. As results of CABG are improving, surgeons are taking up more challenging patient cases and operating on high-risk patients. At the same time, the results of individual surgeons and institutes are coming under greater scrutiny. As most units now conduct regular audits, it is inevitable that LIMA usage will be perceived as a measure of quality. There are some limitations which may affect the conclusions drawn from our study. These include the retrospective observational design of the study. We have used propensity score adjustment to account for this, however this is no substitute for a properly designed randomized controlled trial. On the other hand, retrospective comparisons with propensity score adjustment are more versatile and may be more widely acceptable than randomized control trials [14]. A further limitation is that we have only assessed all-cause mortality rates, which means that cardiac related deaths are potentially overpredicted; however, we do not expect this to considerably affect our conclusions as the chances of a noncardiac related death are equal in both groups. This study also does not assess other long-term outcomes for these patients (eg, graft patency, reintervention rates, and quality of life). Such outcomes will be of interest as our experience grows. A final limitation of the study is the fact that we were only able to obtain a reason for nonusage in 52.1% of patient cases where the LIMA was not used. A more complete picture will become available to us in the next year or two with prospectively collected reasons for nonusage of LIMA. In conclusion, there has been a steady increase in LIMA to LAD grafting at our center during the study period. LIMA was not associated with in-hospital mortality and morbidity; however, there is a notable mortality advantage in LIMA patients over a period of 4 years after surgery. This study looks at reasons for nonusage of LIMA. The common reasons for not using the LIMA are damage during harvesting, poor flow in the LIMA after harvesting, and patients with poor lung functions/coad each of these being seen in at least 1% of the patient population. This study has also helped us identify patient groups in whom LIMA to LAD usage could be increased further. These groups include females, the obese, patients older than 70 years, and those undergoing emergency revascularization. We believe that maximizing LIMA to LAD usage is important, as it is quite likely to become a quality improvement marker for coronary artery bypass surgery. We would like to acknowledge the cooperation given to us by all of the Consultant Cardiac Surgeons at the Cardiothoracic Centre-Liverpool: John A. C. Chalmers, Walid C. Dihmis, Brian M. Fabri, Elaine M. Griffiths, Neeraj K. Mediratta, Richard D. Page, D. Mark Pullan, Abbas Rashid, and W. Ian Weir. We would also like to thank Janet Deane, who is responsible for maintaining the quality and ensuring the completeness of the data collected in our Cardiac Surgery Registry. References Green GE, Strertzer SH, Reppert EH. Coronary arterial bypass grafts. Ann Thorac Surg 1968;5: Lytle BW, Loop FD, Cosgrove FD, et al. Long-term (5 12 years) serial studies of internal mammary artery, and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89: Loop FD, Lytle BW, Cosgrove DM, et al. Influence of internal mammary artery graft on 10-year survival and other cardiac events. N Engl J Med 1986;314: Cameron AA, Green GE, Brogno DA, et al. Internal thoracic artery grafts: 20-year clinical follow-up. J Am Coll Cardiol 1995;25: Grover FL, Johnson RR, Marshall G, et al. Impact of mammary grafts on coronary bypass operative mortality and morbidity. Ann Thorac Surg 1994;57: Edwards FH, Clark RE, Schwartz M. Impact of internal mammary artery conduits on operative mortality in coronary revascularization. Ann Thorac Surg 1994;57: Leavitt BJ, O Connor GT, Olmstead EM, et al. Use of internal mammary artery graft and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation 2001;103: Cohn LH. Use of Internal Mammary Artery graft and inhospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation 2001;103: Wynne-Jones K, Jackson M, Grotte G, et al. On behalf of the north west regional cardiac surgery audit steering group. CARDIOVASCULAR
7 148 KARTHIK ET AL Ann Thorac Surg USE OF THE LIMA TO LAD 2004;78:142 8 Limitations of the Parsonnet score for measuring risk stratified mortality in the north west of England. Heart 2000;84: Mangram AJ, Horan TC, Pearson ML, et al. The Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, Infect Control Hosp Epidemiol 1999;20: Hosmer D, Lemeshow S. Applied logistic regression. New York: Wiley, Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: Cox DR. Regression models and life-tables. J R Stat Soc 1972;34: Blackstone E. Comparing apples and oranges. J Thorac Cardiovasc Surg 2002;123: Cameron A, Davis KB, Green GE, et al. Clinical implications of internal mammary bypass grafts: the coronary artery surgery study experience. Circulation 1988;77: Leavitt BJ, Olmstead EM, Plume SK, et al. Use of the Internal Mammary Artery Graft in Northern New England. Circulation 1997;96(Suppl II): Jones JW, Oschner JL, Mills NL, et al. The internal mammary bypass graft: a superior second coronary artery. J Thorac Cardiovasc Surg 1978;75: Grondin CM, Campeau L, Lesperance J, et al. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation 1984;70:I Sethi GK, Copeland JG, Moritz T, et al. Comparison of postoperative complications between saphenous vein and IMA grafts to left anterior descending coronary. Ann Thorac Surg 1991;51: Dabal RJ, Gross JR, Maynard C, et al. The effect of left internal mammary artery utilization on short-term outcomes after coronary revascularization. Ann Thorac Surg 2003;76: Cleveland JC Jr, Shroyer ALW, Chen AY, et al. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality, and morbidity. Ann Thorac Surg 2001;72: Notice From the American Board of Thoracic Surgery The 2004 Part I (written) examination will be held on Monday, December 6, It is planned that the examination will be given at multiple sites throughout the United States using an electronic format. The closing date for registration is August 1, Those wishing to be considered for examination must apply online at To be admissible to the Part II (oral) examination, a candidate must have successfully completed the Part I (written) examination. A candidate applying for admission to the certifying examination must fulfill all the requirements of the Board in force at the time the application is received. Please address all communications to the American Board of Thoracic Surgery, 633 N St. Clair St, Suite 2320, Chicago, IL 60611; telephone: (312) ; fax: (312) ; info@abts.org by The Society of Thoracic Surgeons Ann Thorac Surg 2004;78: /04/$30.00 Published by Elsevier Inc
Reexploration for Bleeding After Coronary Artery Bypass Surgery: Risk Factors, Outcomes, and the Effect of Time Delay
After Coronary Artery Bypass Surgery: Risk Factors, Outcomes, and the Effect of Time Delay Shishir Karthik, FRCS, Antony D. Grayson, BS, Emer E. McCarron, FRCS, D. Mark Pullan, FRCS(C-Th), and Michael
More informationCoronary Surgery in Patients With Peripheral Vascular Disease: Effect of Avoiding Cardiopulmonary Bypass
Coronary Surgery in Patients With Peripheral Vascular Disease: Effect of Avoiding Cardiopulmonary Bypass Shishir Karthik, FRCS, Ghassan Musleh, FRCS, Antony D. Grayson, BS, Daniel J. M. Keenan, FRCS, D.
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationDiabetes has long been described as an independent
Effect of Risk-Adjusted Diabetes on Mortality and Morbidity After Coronary Artery Bypass Surgery Chandrasahekhar Kubal, MRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Brian M. Fabri, FRCS(Ed),
More informationI internal mammary artery (IMA) is widely accepted as
Routine Use of the Left Internal Mammary Artery Graft in the Elderly Timothy J. Gardner, MD, Peter S. Greene, MD, Mary F. Rykiel, RN, William A. Baumgartner, MD, Duke E. Cameron, MD, Alfred S. Casale,
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationCoronary artery bypass grafting (CABG) is a temporary treatment for a
Surgery for Acquired Cardiovascular Disease Influence of patient characteristics and arterial grafts on freedom from coronary reoperation Joseph F. Sabik III, MD, a Eugene H. Blackstone, MD, a,b A. Marc
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationThe Second Best Arterial Graft:
The Second Best Arterial Graft: A Propensity Analysis of the Radial Artery Versus the Right Internal Thoracic Artery to Bypass the Circumflex Coronary Artery American Association for Thoracic Surgery,
More informationSURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?
SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS? Luigi Martinelli Chief, Dept. of Surgery Istituto Clinico Ligure di Alta Specialità RAPALLO During 1987 2006,
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationIn the United States, 97 million overweight or obese
The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,
More informationDeclaration of conflict of interest NONE
Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationImproved long-term survival has been demonstrated by
Benefit of Bilateral Over Single Internal Mammary Artery Grafts for Multiple Coronary Artery Bypass Grafting Masahiro Endo, MD; Hiroshi Nishida, MD; Yasuko Tomizawa, MD; Hiroshi Kasanuki, MD Background
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationDepartments of Cardiology, Clinical Governance, and Cardiac Surgery, The Cardiothoracic Centre-Liverpool, Liverpool, United Kingdom
Preoperative White Blood Cell Count is Independently Associated With Higher Perioperative Cardiac Enzyme Release and Increased 1-Year Mortality After Coronary Artery Bypass Grafting Nick Newall, MRCP,
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationCoronary atherosclerotic heart disease remains the number
Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,
More informationMinimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases
Original paper Videosurgery Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases Lufeng Zhang, Zhongqi Cui, Zhiming Song, Hang Yang,
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationEuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients
c 2009 Wiley Periodicals, Inc. 637 EuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients Kimiyoshi J. Kobayashi, B.S., Jason A. Williams,
More informationFaculty/Presenter Disclosure
Faculty/Presenter Disclosure Faculty: Andre Lamy Relationships with commercial interests: Grants/Research Support: None Speakers Bureau/Honoraria: None Consulting Fees: None Other: None CORONARY: The Coronary
More informationCONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION
CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION JAMES L ZELLNER MD I have no financial disclosures. 1897
More informationAlthough some renal dysfunction is invariably associated
Valvular Heart Operation Is an Independent Risk Factor for Acute Renal Failure Antony D. Grayson, Magdy Khater, FRCA, Mark Jackson, PhD, and Mark A. Fox, FRCA Departments of Research and Development and
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationIs bypass surgery needed for elderly patients with LMT disease? From the surgical point of view
CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of
More informationRisk Stratification Using The Society of Thoracic Surgeons Program
Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si
More informationDESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft
Measure #43 (NQF 0134): Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS
More informationORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery
ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative
More informationThe number of elderly patients is increasing at an
Arterial Grafting Results in Reduced Operative Mortality and Enhanced Long-Term Quality of Life in Octogenarians Paul A. Kurlansky, MD, Donald B. Williams, MD, Ernest A. Traad, MD, Roger G. Carrillo, MD,
More informationObesity and early complications after cardiac surgery
Obesity and early complications after cardiac surgery Cheng-Hon Yap, Morteza Mohajeri and Michael Yii Despite heightened public awareness that obesity is a major risk factor for cardiac disease and death,
More informationLong-Term Mortality of Coronary Artery Bypass Grafting and Bare-Metal Stenting
Long-Term Mortality of Coronary Artery Bypass Grafting and Bare-Metal Stenting Chuntao Wu, MD, PhD, Songyang Zhao, MS, Andrew S. Wechsler, MD, Stephen Lahey, MD, Gary Walford, MD, Alfred T. Culliford,
More informationModeling and Risk Prediction in the Current Era of Interventional Cardiology
Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.
More informationDecreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England
ORIGINAL ARTICLES: CARDIOVASCULAR Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England Nancy J. O. Birkmeyer, PhD, Charles A. S. Marrin, MBBS, Jeremy R. Morton, MD, Bruce J.
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationEffect of Body Mass Index on Early Outcomes in Patients Undergoing Coronary Artery Bypass Surgery
Journal of the American College of Cardiology Vol. 42, No. 4, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00777-0
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationCoronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy
Coronary Artery Bypass Grafting Versus Coronary Implantation of Sirolimus-Eluting Stents in Patients with Diabetic Retinopathy Takayuki Ohno, MD, Shinichi Takamoto, MD, Noboru Motomura, MD, Minoru Ono,
More informationSupplementary Table S1: Proportion of missing values presents in the original dataset
Supplementary Table S1: Proportion of missing values presents in the original dataset Variable Included (%) Missing (%) Age 89067 (100.0) 0 (0.0) Gender 89067 (100.0) 0 (0.0) Smoking status 80706 (90.6)
More informationSurgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome
Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationOff Pump CABG is Dead. Hopeman Lecture Debate T. Brett Reece, MD September 10, 2007
Off Pump CABG is Dead Hopeman Lecture Debate T. Brett Reece, MD September 10, 2007 OPCAB Potential Pitfalls Technically Demanding Steep learning curve Incomplete revascularization Intraoperative ischemia
More informationThe Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models
The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models A. Laurie W. Shroyer, PhD, Laura P. Coombs, PhD, Eric D. Peterson, MD, Mary C. Eiken, MSN, Elizabeth R. DeLong, PhD,
More informationRisk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery
Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen
More informationCurrent outcomes of off-pump coronary artery bypass grafting: evidence from real world practice
Review Article Current outcomes of off-pump coronary artery bypass grafting: evidence from real world practice Piroze M. Davierwala Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig,
More informationMarc Albert, Adrian Ursulescu, Ulrich FW Franke Department of Cardiovascular Surgery Robert-Bosch-Hospital, Stuttgart, Germany
The total arterial myocardial revascularization using bilateral IMA and the role of post-operative sternal stabilization to reduce wound infections in a large cohort study. Marc Albert, Adrian Ursulescu,
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationPreoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting
Preoperative Prediction of Postoperative Morbidity in Coronary Artery Bypass Grafting Tuula S. O. Kurki, MD, and Matti Kataja, PhD Heart Center, Deaconess Hospital, and National Public Health Institute,
More informationAlfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE
Alfa Ferry FRCS Cardiac Surgeon OPERATIVE MANAGEMENT IN CORONARY ARTERY DISEASE Management in CHD Medical (medikamentosa) Intervensi 1. Percutaneous ( PTCA & stenting ) 2. Surgical ( CABG, CABG & mitral
More informationIs a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?
Interactive CardioVascular and Thoracic Surgery Advance Access published May 7, 2012 Interactive CardioVascular and Thoracic Surgery 0 (2012) 1 5 doi:10.1093/icvts/ivr141 BEST EVIDENCE TOPIC Is a minimally
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationAccepted Manuscript. Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E.
Accepted Manuscript Radial artery and bilateral mammary arteries in CABG: how much is too much? Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc PII: S0022-5223(19)30032-7 DOI: https://doi.org/10.1016/j.jtcvs.2019.01.009
More informationIschemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications
Surgery for Acquired Cardiovascular Disease Ischemic mitral valve reconstruction and replacement: Comparison of long-term survival and complications Eugene A. Grossi, MD Judith D. Goldberg, ScD Angelo
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationCoronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid? Dr. Daniel Navia M.D. Chief Cardiac Surgery Department ICBA, Buenos Aires Argentina, 2018 No disclosures 2 Current evidence The FREEDOM
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationOff-Pump Cardiac Surgery is not Dead
Off-Pump Cardiac Surgery is not Dead Gonzalo J. Carrizo, M.D. Fellow Cardiothoracic Surgery Division Cardiothoracic Surgery Department of Surgery University of Colorado Hopeman Lectureship September 10,2007
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationLong-term survival of patients with pulmonary disease undergoing coronary artery bypass surgery
European Journal of Cardio-Thoracic Surgery 43 (2013) 697 703 doi:10.1093/ejcts/ezs454 Advance Access publication 24 October 2012 ORIGINAL ARTICLE Long-term survival of patients with pulmonary disease
More informationThe MAIN-COMPARE Study
Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative
More informationThe Case for Multivessel Revascularization in Shock
The Case for Multivessel Revascularization in Shock Emmanouil S. Brilakis, MD, PhD Minneapolis Heart Institute 9.37 9.49 am Disclosures Consulting/speaker honoraria: Abbott Vascular, American Heart Association
More informationEvidence-based operational and strategic behavior of
Closing the Loop: Optimizing Physicians Operational and Strategic Behavior Paul T. Sergeant, MD, PhD, and Eugene H. Blackstone, MD Katholieke Universiteit Leuven, Leuven, Belgium, and The Cleveland Clinic
More informationDiabetes mellitus (DM) has been identified as an independent
Diabetes Does Not Affect Long-Term Results After Total Arterial Off-Pump Coronary Revascularization Ho Young Hwang, MD, Jae-Sung Choi, MD, PhD, and Ki-Bong Kim, MD, PhD Department of Thoracic and Cardiovascular
More informationThe clinical and prognostic benefits of coronary artery bypass grafting (CABG)
ORIGINAL ARTICLE Total arterial myocardial revascularization: analysis of initial experience Shahzad Gull Raja, MRCS; Zulfiqar Haider, FRCS; Haider Zaman, FRCS (CTh); Mukhtar Ahmed, FRCS BACKGROUND: Total
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationCopyright by ICR Publishers 2005
Does EuroSCORE Predict Length of Stay and Specific Postoperative Complications after Heart Valve Surgery? Ioannis K. Toumpoulis 1,2, Constantine E. Anagnostopoulos 1,2 1 Columbia University College of
More informationAcute Renal Failure in Coronary Artery Bypass Surgery: Independent Effect of Cardiopulmonary Bypass
Acute Renal Failure in Coronary Artery Bypass Surgery: Independent Effect of Cardiopulmonary Bypass Mark I. Stallwood, FRCA, Antony D. Grayson, BS, Keith Mills, FRCA, and Nigel D. Scawn, FRCA Departments
More informationA Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions
Journal of the American College of Cardiology Vol. 47, No. 3, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.09.071
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationDisclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb
Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes from the Project of Ex-vivo Vein Graft
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationDaryoush Samim, Enrico Ferrari, MD, FETCS, PD&MER
On- pump versus off- pump coronary artery bypass grafting with left internal mammary artery for left anterior descending artery stenosis: a retrospective study over 15 years Daryoush Samim, Enrico Ferrari,
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationCardiac surgery in Victorian public hospitals, Public report
Cardiac surgery in Victorian public hospitals, 2009 10 Public report Cardiac surgery in Victorian public hospitals, 2009 10 Public report Authors: DT Dinh, L Tran, V Chand, A Newcomb, G Shardey, B Billah
More informationOff-Pump Bilateral Internal Thoracic Artery Grafting in Right Internal Thoracic Artery to Right Coronary System
Off-Pump Bilateral Internal Thoracic Artery Grafting in Right Internal Thoracic Artery to Right Coronary System ADULT CARDIAC Hyun-Chel Joo, MD, Young-Nam Youn, MD, PhD, Gijong Yi, MD, PhD, Byung-Chul
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationEffect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival
Effect of Valve Suture Technique on Incidence of Paraprosthetic Regurgitation and 10-Year Survival Sukumaran K. Nair, FRCS (C Th), Gauraang Bhatnagar, MBBS, Oswaldo Valencia, MD, and Venkatachalam Chandrasekaran,
More informationMinimally invasive aortic valve replacement in high risk patient groups
Review Article Minimally invasive aortic valve replacement in high risk patient groups Daniel Fudulu, Harriet Lewis, Umberto Benedetto, Massimo Caputo, Gianni Angelini, Hunaid A. Vohra Department of Cardiac
More informationCoronary artery bypass graft (CABG) operations have
Variation in Hospital Rates of Intraaortic Balloon Pump Use in Coronary Artery Bypass Operations William A. Ghali, MD, MPH, Arlene S. Ash, PhD, Ruth E. Hall, MSc, and Mark A. Moskowitz, MD Health Care
More informationOff-Pump Coronary Artery Bypass Grafting With Skeletonized Bilateral Internal Thoracic Arteries in Insulin-Dependent Diabetics
Off-Pump Coronary Artery Bypass Grafting With Skeletonized Bilateral Internal Thoracic Arteries in Insulin-Dependent Diabetics Masashi Kai, MD, Michiya Hanyu, MD, PhD, Yoshiharu Soga, MD, PhD, Takuya Nomoto,
More informationManagement during Reoperation of Aortocoronary Saphenous Vein Grafts with Minimal Atherosclerosis by Angiography
Management during Reoperation of ortocoronary Saphenous Vein Grafts with therosclerosis by ngiography William G. Marshall, Jr., M.D., Jeffrey Saffitz, M.D., and Nicholas T. Kouchoukos, M.D. STRCT The proper
More informationOn-Pump Beating-Heart Coronary Artery Bypass: A Propensity Matched Analysis
On-Pump Beating-Heart Coronary Artery Bypass: A Propensity Matched Analysis Shinichi Mizutani, MD, Akio Matsuura, MD, Ken Miyahara, MD, Tadahito Eda, MD, Akemi Kawamura, MD, Teruaki Yoshioka, MD, and Katsuhiko
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationUniversity of Bristol - Explore Bristol Research
Rogers, C., Capoun, R., Scott, L., Taylor, J., Angelini, G., Narayan, P.,... Ascione, R. (2017). Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results
More informationand Paul C. Taylor, M.D. ORIGINAL ARTICLES
ORIGINAL ARTICLES Trends in Selection and Results of Coronary Artery Reoperations Floyd D. Loop, M.D., Bruce W. Lytle, M.D., Carl C. Gill, M.D., Leonard A. R. Golding, M.D., Delos M. Cosgrove, M.D., and
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationHOW TO PREPARE A GOOD ACCEPTED
HOW TO PREPARE A GOOD ABSTRACT AND GET IT ACCEPTED This is an interactive session; be free to interrupt and ask questions at any time during the talk! Some useful points when deciding if and where to submit
More informationDuring the last years, many reports have clearly
Single Versus Bilateral Internal Mammary Artery for Isolated First Myocardial Revascularization in Multivessel Disease: Long-Term Clinical Results in Medically Treated Diabetic Patients Antonio Maria Calafiore,
More informationCORONARY ARTERY BYPASS GRAFTING (CABG) (Part 1) Mark Shikhman, MD, Ph.D., CSA Andrea Scott, CST
CORONARY ARTERY BYPASS GRAFTING (CABG) (Part 1) Mark Shikhman, MD, Ph.D., CSA Andrea Scott, CST I have constructed this lecture based on publications by leading cardiothoracic American surgeons: Timothy
More informationPredictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;
More information